Uncemented total hip implant and subcutaneous injection of Denosumab for patients with osteoarthritis of the hip. A randomised double blind placebo controlled study on the effects on bone evaluated with DXA, PET/CT, and biochemical markers.

Trial Profile

Uncemented total hip implant and subcutaneous injection of Denosumab for patients with osteoarthritis of the hip. A randomised double blind placebo controlled study on the effects on bone evaluated with DXA, PET/CT, and biochemical markers.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 May 2017

At a glance

  • Drugs Denosumab (Primary)
  • Indications Osteoporosis
  • Focus Biomarker; Therapeutic Use
  • Acronyms DATA
  • Most Recent Events

    • 04 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 26 May 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
    • 17 Mar 2015 Planned End Date changed from 1 Jul 2017 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top